Highlights in Therapy: Hairy Cell Leukemia
Join Leslie A. Andritsos, MD, Professor of Internal Medicine, Division of Hematology/ Oncology, at the University of New Mexico Comprehensive Cancer Center in Albuquerque, NM as she discusses current and emerging therapies for hairy cell leukemia (HCL), treatment for relapsed/refractory HCL, side-effect management, and advocating for quality-of-life concerns.
▶︎
What’s New and What’s Next
▶︎
Expanded Access (Compassionate Use) in Treating Pediatric Oncology
▶︎
WHY EXPERIENCED DIVERS STILL DIE | THE HIDDEN RISKS OF EXPERIENCE
▶︎
Hairy Cell Leukemia - CRASH! Medical Review Series
▶︎
Recurrent Ovarian Cancer: Treatment Options, Symptoms & Making Decisions | Expert Guide (2025)
▶︎
New frontiers in hematology
▶︎
Bloodline Breakthroughs: innovations & inspiration | Polycythemia vera (PV)
▶︎
Multiple Myeloma in 2025 and Treatment Options
▶︎
Managing CML: What HCPs Need to Know
▶︎
Educational series #11: Treatment-resistant depression
▶︎
Anna Holmes, Cell therapies
▶︎
The State of Lyme Disease Research & Legislative Update Spring 2026
▶︎
Pediatric Acute Leukemias: Clinical Trials for Treatment
▶︎
#ExpertTalk: CNM-Au8 Long-term Evidence & EAP Program Update | Rob Etherington & Dr. Marjan Sepassi
▶︎
How Specialists Use Echo to Monitor Your PAH: PAH Today national broadcast
▶︎
Stem Cell Therapy - Is It Worth It? My Treatment & Results
▶︎
How Long Can I Live with CLL? (Chronic Lymphocytic Leukemia) | The Patient Story
▶︎
Follicular Lymphoma Treatment Decisions: What’s Right for You?
▶︎
2026 RUNX1 Patient Meeting: NIH RUNX1 Clinical Research Study Update with Dr. David Young
▶︎